Rita Jain - Apr 3, 2023 Form 4 Insider Report for ANAPTYSBIO, INC (ANAB)

Role
Director
Signature
/s/ Eric Loumeau, Attorney-in-Fact
Stock symbol
ANAB
Transactions as of
Apr 3, 2023
Transactions value $
$0
Form type
4
Date filed
4/6/2023, 05:05 PM
Previous filing
Feb 21, 2023
Next filing
Apr 27, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ANAB Stock Option (right to buy) Award $0 +10.6K $0.00 10.6K Apr 3, 2023 Common Stock 10.6K $22.09 Direct F1
transaction ANAB Stock Option (right to buy) Award $0 +8.02K $0.00 8.02K Apr 3, 2023 Common Stock 8.02K $22.09 Direct F2
transaction ANAB Restricted Stock Unit Award $0 +3.9K $0.00 3.9K Apr 3, 2023 Common Stock 3.9K Direct F3, F4
transaction ANAB Restricted Stock Unit Award $0 +3.23K $0.00 3.23K Apr 3, 2023 Common Stock 3.23K Direct F3, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock option vests as of 1/36 of the total shares monthly beginning on May 6, 2023 until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date.
F2 The stock option vests as of 1/9 of the total shares monthly beginning on May 6, 2023 and each month thereafter until fully vested on January 6, 2024, subject to the Reporting Person's provision of service to the Issuer on each vesting date.
F3 Each restricted stock unit ("RSU") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration.
F4 The RSUs shall vest as to 1/3 of the total shares on June 15, 2024, and thereafter vests as to 1/3 of the total RSUs on June 15, 2025; and as to 1/3 of the total RSUs on June 15, 2026, subject to the provision of services to the Company on each vesting date.
F5 The RSUs vests as to 100% of the total RSUs on the date of the Issuer's 2024 annual meeting of shareholders, subject to the Reporting Person's provision of service to the Issuer on each vesting date.